Published in J Cancer Res Clin Oncol on January 09, 2010
Glutathione transferases. Annu Rev Pharmacol Toxicol (2005) 9.67
Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J (2001) 4.75
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev (2000) 3.42
Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol (1990) 2.31
Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer (2000) 2.16
N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene (2006) 2.03
A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem (1996) 1.78
The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol (2003) 1.72
Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature (1994) 1.31
Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet (1995) 1.30
Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res (1995) 1.19
Glutathione S-transferase-mu (GSTM1) and -theta (GSTT1) genotypes in the etiology of prostate cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.11
Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis (1994) 1.08
The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder. J Urol (1987) 1.07
Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett (2005) 1.05
Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Natl Cancer Inst (1994) 1.03
Cancer in Jewish migrants to Israel. Int J Cancer (1990) 1.01
Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett (1998) 0.98
Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis (2002) 0.97
Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer (1999) 0.96
Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett (1998) 0.90
Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis (2000) 0.90
GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev (1998) 0.87
N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev (2000) 0.87
Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma (1998) 0.85
Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells. Carcinogenesis (1994) 0.81
The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol (2007) 0.79
Do smoking and polymorphisms in xenobiotic metabolizing enzymes affect the histological stage and grade of bladder tumors? Bull Cancer (2009) 0.77
[Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer]. Zhonghua Zhong Liu Za Zhi (2004) 0.76
Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res (2011) 0.92
Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes. Acta Diabetol (2011) 0.90
The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development. BMC Cancer (2011) 0.87
Expression of WISP3 and RhoC genes at mRNA and protein levels in inflammatory and noninflammatory breast cancer in Tunisian patients. Cancer Invest (2010) 0.85
Methylenetetrahydrofolate reductase and methionine synthase polymorphisms and risk of bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2007) 0.84
NY-ESO-1 expression and immunogenicity in prostate cancer patients. Tunis Med (2011) 0.84
Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumour Biol (2013) 0.83
A meta-analysis of the relationship between FGFR3 and TP53 mutations in bladder cancer. PLoS One (2012) 0.82
Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.82
Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biol (2014) 0.82
Combined effect of NAT2, MTR and MTHFR genotypes and tobacco on bladder cancer susceptibility in Tunisian population. Cancer Detect Prev (2009) 0.81
Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet (2009) 0.80
CD99 and HLA-II immunostaining in breast cancer tissue and their correlation with lymph node metastasis. Dis Markers (2013) 0.80
The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol (2007) 0.79
Combined analysis of smoking, TP53, and FGFR3 mutations in Tunisian patients with invasive and superficial high-grade bladder tumors. Cancer Invest (2009) 0.79
Association analysis of LCE3C-LCE3B deletion in Tunisian psoriatic population. Arch Dermatol Res (2012) 0.78
MTHFR gene polymorphisms and bladder cancer susceptibility: a meta-analysis including race, smoking status and tumour stage. Asian Pac J Cancer Prev (2011) 0.78
Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors. Bull Cancer (2011) 0.78
Protozoan parasite aquaporins. Expert Rev Proteomics (2009) 0.78
3020insC NOD2/CARD15 polymorphism associated with treatment of colorectal cancer. Med Oncol (2014) 0.78
Somatic mutation of MutYH in Tunisian patients with sporadic colorectal cancer. J Clin Lab Anal (2007) 0.77
Structural analysis of two novel mutations in MCFD2 gene causing combined coagulation factors V and VIII deficiency. Blood Cells Mol Dis (2009) 0.77
In vivo prevention of bladder urotoxicity: purified hydroxytyrosol ameliorates urotoxic effects of cyclophosphamide and buthionine sulfoximine in mice. Int J Toxicol (2011) 0.76
First genetic analysis in Tunisian familial adenomatous polyposis probands. Oncol Rep (2008) 0.76
Prevalence of mutations in APC, CTNNB1, and BRAF in Tunisian patients with sporadic colorectal cancer. Cancer Genet Cytogenet (2008) 0.76
Experimental and computational studies indicate specific binding of pVHL protein to Aurora-A kinase. J Phys Chem B (2010) 0.76
Influence of socioeconomic lifestyle factors and genetic polymorphism on type 2 diabetes occurrences among Tunisian Arab and Berber groups of Djerba Island. Pharmgenomics Pers Med (2009) 0.75
HLA class II alleles and multiple sclerosis in Tunisian patients. Clin Neurol Neurosurg (2010) 0.75
The role of CYP2D6*4 variant in bladder cancer susceptibility in Tunisian patients. Bull Cancer (2008) 0.75
Capture of sunflower seedlings lipase using polyclonal antibodies. Nat Prod Res (2012) 0.75
Breast cancer in Tunisia: association of body mass index with histopathological aspects of tumors. Asian Pac J Cancer Prev (2014) 0.75
Do we know all there is to know about Familial Adenomatous Polyposis? Gastroenterol Clin Biol (2007) 0.75
Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr Res (2012) 0.75
[Does multiple myeloma response to induction therapy depend on plasma cell IL6 receptor gene expression?]. Tunis Med (2013) 0.75
Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence. Med Oncol (2014) 0.75
Polymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population. Leuk Lymphoma (2014) 0.75